Pneumonia Nosode

FDA Drug Profile — Pneumonia Nosode 4016

Drug Details

Generic Name
Pneumonia Nosode
Brand Names
Pneumonia Nosode 4016
Application Number
Sponsor
Professional Complementary Health Formulas
NDC Codes
1
Dosage Forms
LIQUID
Routes
ORAL
Active Ingredients
CHLAMYDIA TRACHOMATIS, CHLAMYDOPHILA PSITTACI, COCCIDIOIDES IMMITIS WHOLE, COXIELLA BURNETII, COXSACKIEVIRUS A21, HAEMOPHILUS INFLUENZAE, HISTOPLASMA CAPSULATUM, HUMAN ADENOVIRUS B SEROTYPE 3, HUMAN RESPIRATORY SYNCYTIAL VIRUS, INFLUENZA A VIRUS A/VICTORIA/2454/2019 IVR-207 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), KLEBSIELLA PNEUMONIAE, MYCOBACTERIUM TUBERCULOSIS, MYCOPLASMA PNEUMONIAE, RICKETTSIA RICKETTSII, STAPHYLOCOCCUS AUREUS, STREPTOCOCCUS PYOGENES, STREPTOCOCCUS VIRIDANS GROUP

Indications and Usage

INDICATIONS For the temporary relief of cough, congestion, chills, difficulty breathing, or feelings of discomfort or uneasiness.*

Warnings

WARNINGS Persistent symptoms may be a sign of a serious condition. Consult a doctor promptly if symptoms persist or are accompanied by a fever. Keep out of the reach of children. In case of overdose, get medical help or contact a poison control center right away. If pregnant or breastfeeding, ask a healthcare professional before use. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.